{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"primary-hyperoxaluria-type-3","columns":[{"gene":"","key":"population-f9f5d2fe98e54d593c4f","label":"Hyperoxaluria, primary, type III","mondoId":"MONDO:0013327","onsetQualifier":null,"originColumnKey":"MONDO:0013327/OMIM:613616","originalViews":[{"key":"MONDO:0013327/OMIM:613616","label":"Hyperoxaluria, primary, type III","scopeLabel":"OMIM:613616","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["0f25a88c1d697f50b45c086ceace8d6bd3c882beaa2a393a465922645fe53702","3e4873c2077d114876b6aa85fbfc7abaa8762153d6aeb0acb67375520936591d","48b5cb375ef1b75adf1c3d4c757d785338c5d7a84ab4a7e75d1a0c3f9cd2c03b"],"recordQualifiers":{},"scopeLabel":"OMIM:613616","sourceIds":["OMIM:613616"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"population-9b1426e6a185e1533a5f","label":"Primary hyperoxaluria type 3","mondoId":"MONDO:0013327","onsetQualifier":null,"originColumnKey":"MONDO:0013327/ORPHA:93600","originalViews":[{"key":"MONDO:0013327/ORPHA:93600","label":"Primary hyperoxaluria type 3","scopeLabel":"ORPHA:93600","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["066c50540b005e9739a99b609ff90a180bc95daa3353dbe53b3b59223d6d4237","119dcc617eda893e8a1f4a1db1381b3ff9772f802bd2821024c1b46d2deb0ade","4a9a99e73a91d403ee1de43559ba68938fd2f76f388972dcb2356d11e5a330b2","5d743d276515e7e4ac6df5279ef23f664c01d0b55dfcaee6c5bd1ab1a4982a87","72950b28fa38a08c492ab96786225a9c423ecb2111e63a618c83ba3a3ea66158","8e9392c58c4cd81c61615db40939ff4d07ac1f06422bf8cb2be3c7aa0dfe1969","a29d71870070c32385639f88160fa661334a3b13c4d917de2da69670e99d4e05","ba58df543a473b536b22fbb325846f1edba5b9fa7ba47f1a102f17d80c77f828","eae073230a6df989e8b4aae7d019ed1d699d7bbd95d185e46402a318f89e84e5"],"recordQualifiers":{},"scopeLabel":"ORPHA:93600","sourceIds":["ORPHA:93600"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-f9f5d2fe98e54d593c4f","population-9b1426e6a185e1533a5f"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0012211","HP:0003110","HP:0008672","HP:0100518","HP:0000790","HP:0003159","HP:6001009"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":12,"sourceGroups":{"orphanet":9,"published":3}},"features":[{"hpoId":"HP:0012211","label":"Abnormal renal physiology","primary":true},{"hpoId":"HP:0003110","label":"Abnormality of urine homeostasis","primary":true},{"hpoId":"HP:0008672","label":"Calcium oxalate nephrolithiasis","primary":true},{"hpoId":"HP:0100518","label":"Dysuria","primary":true},{"hpoId":"HP:0000790","label":"Hematuria","primary":true},{"hpoId":"HP:0003159","label":"Hyperoxaluria","primary":true},{"hpoId":"HP:6001009","label":"Increased urine 4-hydroxy-2-oxoglutarate level","primary":true},{"hpoId":"HP:0000121","label":"Nephrocalcinosis","primary":false},{"hpoId":"HP:0012531","label":"Pain","primary":false},{"hpoId":"HP:0100515","label":"Pollakisuria","primary":false}],"ledeHtml":"Primary hyperoxaluria type 3 (PH3) is a disorder of glyoxylate metabolism that can be asymptomatic or characterized by oxalate nephrolithiasis.","mondoId":"MONDO:0013327","node":{"canonicalSlug":"primary-hyperoxaluria-type-3","comparisons":[{"documentSha256":"e0d61b441f613dc5c4be209ea02f815ea23c5e26f673dc1c0451d7efa28eaa8f","key":"legacy-primary-hyperoxaluria","kind":"legacy","label":"primary hyperoxaluria","memberIds":["MONDO:0002474","MONDO:0009824","MONDO:0013327"],"mondoId":"MONDO:0002474","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/primary-hyperoxaluria.e0d61b441f613dc5c4be209ea02f815ea23c5e26f673dc1c0451d7efa28eaa8f.json"},{"documentSha256":"154b805a82b66671d7fe404fae2eef490c2a51bb1d56920205679a4096052bd3","key":"expanded-primary-hyperoxaluria","kind":"expanded","label":"primary hyperoxaluria","memberIds":["MONDO:0002474","MONDO:0009823","MONDO:0009824","MONDO:0013327"],"mondoId":"MONDO:0002474","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-154b805a82b66671d7fe.154b805a82b66671d7fe404fae2eef490c2a51bb1d56920205679a4096052bd3.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Primary hyperoxaluria type 3","originalSourceId":"ORPHA:93600","paragraphs":["Primary hyperoxaluria type 3 (PH3) is a disorder of glyoxylate metabolism that can be asymptomatic or characterized by oxalate nephrolithiasis."],"rawAttribution":"MONDO:0013327","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:19Z","upstream":"MONDO:0013327","url":"https://rarediseases.info.nih.gov/diseases/10738"},"ownColumnKeys":["population-f9f5d2fe98e54d593c4f","population-9b1426e6a185e1533a5f"],"publication":"published","relationships":[{"kind":"parent","label":"primary hyperoxaluria","mondoId":"MONDO:0002474","slug":"primary-hyperoxaluria"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Clinical-characteristics text absent or chapter identity requires review","source":"GeneReviews","url":"https://www.ncbi.nlm.nih.gov/books/NBK316514/"}],"translation":"published"},"records":[{"frequencyKind":"range","key":"066c50540b005e9739a99b609ff90a180bc95daa3353dbe53b3b59223d6d4237","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:93600","disease_name":"Primary hyperoxaluria type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003110","is_excluded":false,"label":"Abnormality of urine homeostasis","onset_id":null,"reference":"ORPHA:93600","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"0f25a88c1d697f50b45c086ceace8d6bd3c882beaa2a393a465922645fe53702","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:613616","disease_name":"Hyperoxaluria, primary, type III","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0008672","is_excluded":false,"label":"Calcium oxalate nephrolithiasis","onset_id":null,"reference":"PMID:20797690","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"119dcc617eda893e8a1f4a1db1381b3ff9772f802bd2821024c1b46d2deb0ade","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:93600","disease_name":"Primary hyperoxaluria type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003159","is_excluded":false,"label":"Hyperoxaluria","onset_id":null,"reference":"ORPHA:93600","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"3e4873c2077d114876b6aa85fbfc7abaa8762153d6aeb0acb67375520936591d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613616","disease_name":"Hyperoxaluria, primary, type III","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:6001009","is_excluded":false,"label":"Increased urine 4-hydroxy-2-oxoglutarate level","onset_id":null,"reference":"PMID:26401545","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"48b5cb375ef1b75adf1c3d4c757d785338c5d7a84ab4a7e75d1a0c3f9cd2c03b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613616","disease_name":"Hyperoxaluria, primary, type III","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003159","is_excluded":false,"label":"Hyperoxaluria","onset_id":null,"reference":"PMID:20797690","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"4a9a99e73a91d403ee1de43559ba68938fd2f76f388972dcb2356d11e5a330b2","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93600","disease_name":"Primary hyperoxaluria type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012211","is_excluded":false,"label":"Abnormal renal physiology","onset_id":null,"reference":"ORPHA:93600","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5d743d276515e7e4ac6df5279ef23f664c01d0b55dfcaee6c5bd1ab1a4982a87","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93600","disease_name":"Primary hyperoxaluria type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0100515","is_excluded":false,"label":"Pollakisuria","onset_id":null,"reference":"ORPHA:93600","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"72950b28fa38a08c492ab96786225a9c423ecb2111e63a618c83ba3a3ea66158","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:93600","disease_name":"Primary hyperoxaluria type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012531","is_excluded":false,"label":"Pain","onset_id":null,"reference":"ORPHA:93600","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8e9392c58c4cd81c61615db40939ff4d07ac1f06422bf8cb2be3c7aa0dfe1969","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93600","disease_name":"Primary hyperoxaluria type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000121","is_excluded":false,"label":"Nephrocalcinosis","onset_id":null,"reference":"ORPHA:93600","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a29d71870070c32385639f88160fa661334a3b13c4d917de2da69670e99d4e05","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93600","disease_name":"Primary hyperoxaluria type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0100518","is_excluded":false,"label":"Dysuria","onset_id":null,"reference":"ORPHA:93600","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ba58df543a473b536b22fbb325846f1edba5b9fa7ba47f1a102f17d80c77f828","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:93600","disease_name":"Primary hyperoxaluria type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000790","is_excluded":false,"label":"Hematuria","onset_id":null,"reference":"ORPHA:93600","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"eae073230a6df989e8b4aae7d019ed1d699d7bbd95d185e46402a318f89e84e5","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:93600","disease_name":"Primary hyperoxaluria type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008672","is_excluded":false,"label":"Calcium oxalate nephrolithiasis","onset_id":null,"reference":"ORPHA:93600","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10738\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0013327\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0013327</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Primary hyperoxaluria type 3 (PH3) is a disorder of glyoxylate metabolism that can be asymptomatic or characterized by oxalate nephrolithiasis.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10738\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"primary-hyperoxaluria-type-3","sourceDocuments":[{"name":"GARD: Primary hyperoxaluria type 3","reviewed":null,"source_release":"2026-10-25T03:41:19Z","url":"https://rarediseases.info.nih.gov/diseases/10738"},{"name":"MONDO: primary hyperoxaluria type 3","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0013327"}],"sourceNote":"","synonyms":["HOGA1 primary hyperoxaluria","HP3","hyperoxaluria, primary, type III","PH III","primary hyperoxaluria caused by mutation in HOGA1","primary hyperoxaluria type III"],"takeawayHtml":"","title":"primary hyperoxaluria type 3"},"schemaVersion":1}
